Best Burkitt"s lymphoma hematologist-oncologists in Spain: TOP 7 doctors

• Dr. Jaume Mora Graupera specializes in Burkitt's lymphoma treatment, using chemotherapy, immunotherapy, and targeted therapy.
• He trained in pediatric hematology oncology at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA.
• He is the Director of the Hematology Oncology Department and the Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital.
• He is a member of the International Society of Pediatric Oncology and the American Society of Clinical Oncology.
• Fluent in English and Spanish, he provides comprehensive care to patients from around the world.

• Specializes in Burkitt's lymphoma treatment with advanced chemotherapy, immunotherapy, and bone marrow transplantation.
• Received training at medical institutions in Spain, the United States, and the United Kingdom.
• Head of the Center of Bone Marrow Transplantation, leading innovative treatment protocols.
• Member of the European Society for Pediatric Hematology/Oncology and the American Society of Hematology.
• Fluent in English, Spanish, and Catalan, enabling effective communication with patients.

• Dr. Susana Rives Sola is a renowned children's hematologist specializing in Burkitt's lymphoma treatment.
• She utilizes chemotherapy, immunotherapy, targeted therapy, and bone marrow transplantation for Burkitt's lymphoma.
• Dr. Rives Sola has trained and practiced at medical institutions in the USA and Spain.
• She is a member of the European Society for Paediatric Haematology and Immunology.
• Fluent in English and Spanish, Dr. Rives Sola provides comprehensive care for her patients.

Dr. Blanca Lopez Ibor is an experienced specialist in children’s hematology and oncology from Spain. She is a lecturer at the Universidad Complutense de Madrid and Universidad CEU San Pablo, and is a consultant for the WHO and UNESCO. Dr Lopez Ibor has over 30 years of experience diagnosing and treating hematological and cancer disorders in children. She is also the head of two foundations that help children with severe health problems.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.